LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 1401 | 665 | 4272 | 0.1557 | -0.3710 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 1 | F01 | 72 | hr | 1401 | 1104 | 3978 | 0.2775 | -0.1466 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 2 | F01 | 72 | hr | 1401 | 894 | 4213 | 0.2122 | -0.2466 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 3 | F01 | 72 | hr | 1401 | 1191 | 4545 | 0.2620 | -0.0914 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 1401 | 4442 | 4139 | 1.0732 | 1.0925 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 1401 | 4195 | 4095 | 1.0243 | 1.0313 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 1401 | 4642 | 4272 | 1.0865 | 1.1059 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 1 | I11 | 72 | hr | 1401 | 4387 | 4139 | 1.0599 | 1.0759 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 2 | I11 | 72 | hr | 1401 | 4067 | 4095 | 0.9931 | 0.9910 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 1401 | 4264 | 4272 | 0.9980 | 0.9976 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 1401 | 4689 | 4139 | 1.1329 | 1.1663 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 1401 | 3957 | 4095 | 0.9662 | 0.9561 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 1401 | 4192 | 4272 | 0.9812 | 0.9765 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1401 | 4765 | 4139 | 1.1512 | 1.1887 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1401 | 4540 | 4095 | 1.1086 | 1.1378 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1401 | 4054 | 4272 | 0.9489 | 0.9358 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 1401 | 4742 | 4139 | 1.1457 | 1.1819 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 1401 | 4545 | 4095 | 1.1098 | 1.1393 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 1401 | 3653 | 4272 | 0.8550 | 0.8144 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 1 | I07 | 72 | hr | 1401 | 2336 | 4139 | 0.5644 | 0.3868 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 1401 | 2290 | 4095 | 0.5592 | 0.3735 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 1401 | 2347 | 4272 | 0.5494 | 0.3780 |
| SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 1401 | 3584 | 3978 | 0.9008 | 0.8659 |
| SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 1401 | 3743 | 4213 | 0.8884 | 0.8564 |
| SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 1401 | 3857 | 4545 | 0.8485 | 0.8155 |